Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
Crossref DOI link: https://doi.org/10.1007/s10552-015-0678-1
Published Online: 2015-10-12
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rozemeijer, Kirsten
Penning, Corine
Siebers, Albert G.
Naber, Steffie K.
Matthijsse, Suzette M.
van Ballegooijen, Marjolein
van Kemenade, Folkert J.
de Kok, Inge M. C. M.
License valid from 2015-10-12